189 related articles for article (PubMed ID: 12240550)
1. Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
Stranzl H; Gabor S; Mayer R; Prettenhofer U; Wurzinger G; Hackl A
Strahlenther Onkol; 2002 Aug; 178(8):442-5. PubMed ID: 12240550
[TBL] [Abstract][Full Text] [Related]
2. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
Chang LF; Horvath J; Peyton W; Ling SS
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
[TBL] [Abstract][Full Text] [Related]
3. [High-dose endobronchial brachytherapy in malignant tumors of the lung].
Escobar Sacristán J; de Granda Orive JI; Gutiérrez Jiménez T; Martínez Albiach JM; Fuentes Ramos M; Herrera de la Rosa A
Arch Bronconeumol; 1997 Jun; 33(6):278-83. PubMed ID: 9289322
[TBL] [Abstract][Full Text] [Related]
4. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
[TBL] [Abstract][Full Text] [Related]
5. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
6. Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors.
Niemoeller OM; Pöllinger B; Niyazi M; Corradini S; Manapov F; Belka C; Huber RM
Radiat Oncol; 2013 Jan; 8():8. PubMed ID: 23289530
[TBL] [Abstract][Full Text] [Related]
7. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
8. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Corner C; Bryant L; Chapman C; Glynne-Jones R; Hoskin PJ
Brachytherapy; 2010; 9(1):66-70. PubMed ID: 19846349
[TBL] [Abstract][Full Text] [Related]
10. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
11. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
[TBL] [Abstract][Full Text] [Related]
12. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions.
Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A
Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560
[TBL] [Abstract][Full Text] [Related]
13. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma.
Ofiara L; Roman T; Schwartzman K; Levy RD
Chest; 1997 Oct; 112(4):946-53. PubMed ID: 9377957
[TBL] [Abstract][Full Text] [Related]
14. High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Hoskin PJ; de Canha SM; Bownes P; Bryant L; Glynne Jones R
Radiother Oncol; 2004 Nov; 73(2):195-8. PubMed ID: 15542167
[TBL] [Abstract][Full Text] [Related]
15. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
[TBL] [Abstract][Full Text] [Related]
16. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.
Nori D; Allison R; Kaplan B; Samala E; Osian A; Karbowitz S
Chest; 1993 Oct; 104(4):1006-11. PubMed ID: 7691481
[TBL] [Abstract][Full Text] [Related]
17. High dose rate intraluminal radiotherapy for carcinoma of the bronchus: outcome of treatment of 406 patients.
Gollins SW; Burt PA; Barber PV; Stout R
Radiother Oncol; 1994 Oct; 33(1):31-40. PubMed ID: 7533304
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience.
Kelly JF; Delclos ME; Morice RC; Huaringa A; Allen PK; Komaki R
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):697-702. PubMed ID: 11020566
[TBL] [Abstract][Full Text] [Related]
19. Endobronchial brachytherapy in the treatment of malignant lung tumours.
Escobar-Sacristán JA; Granda-Orive JI; Gutiérrez Jiménez T; Delgado JM; Rodero Baños A; Saez Valls R
Eur Respir J; 2004 Sep; 24(3):348-52. PubMed ID: 15358689
[TBL] [Abstract][Full Text] [Related]
20. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]